Cargando…
Oxidized-Desialylated Low-Density Lipoprotein Inhibits the Antitumor Functions of Lymphokine Activated Killer Cells
Elevated concentrations of circulating low density lipoprotein (LDL) that is abnormally oxidized and desialylated is both a precursor to and a hallmark of atherosclerosis. Peripheral blood mononuclear cells (PBMCs) treated in vitro with interleukin-2 (IL-2) become lymphokine activated killer (LAK) c...
Autores principales: | Aguilar Díaz de león, Jesús S, Glenn, Honor L, Knappenberger, Mark, Borges, Chad R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247392/ https://www.ncbi.nlm.nih.gov/pubmed/34234868 http://dx.doi.org/10.7150/jca.55526 |
Ejemplares similares
-
Neuraminidases 1 and 3 Trigger Atherosclerosis by Desialylating Low‐Density Lipoproteins and Increasing Their Uptake by Macrophages
por: Demina, Ekaterina P., et al.
Publicado: (2021) -
Thirty-Five-Year History of Desialylated Lipoproteins Discovered by Vladimir Tertov
por: Glanz, Victor, et al.
Publicado: (2022) -
Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.
por: Rajaram, N., et al.
Publicado: (1990) -
Lymphokine-activated killer cells. Analysis of progenitors and effectors
Publicado: (1986) -
Characterization of Transendothelial Migratory Lymphokine‐activated Killer Cells
por: Nakano, Koji, et al.
Publicado: (1996)